MYC and neoplasm: Sgg can enlist CD11b+TLR4+ cells, promoting the expression of IL-8, COX-2, and IL-1, and escalating the levels of tumor progression-related transcription factors like β-catenin, c-Myc, and PCNA, thereby driving inflammation and facilitating tumor proliferation (95–98).